Device, method and assembly for wound treatment. Specifically a wound dressing device; an assembly, e.g. a kit-of-parts, including the device as a component; and method of wound dressing and use wherein the device is a key component. The device includes a cavity defined by concave walls surrounded by lips for attachment to skin in fluid tight manner and a closure removably fixed to the lips and sealing the cavity. The assembly also includes, as another component a device for introducing blood into the cavity after it is fixed over a wound to permit the blood to clot over the wound within the cavity. In use, the clotting mold device is fixed on top of a wound, and blood is introduced into the mold space to permit the blood to clot within the mold space to form a blood clot over the wound.

Described herein are support devices, which may include medical support devices. In particular, three-dimensional medical (and non-medical) devices from a single layer of material, typically by stamping or pressing (including cold pressing) a sheet of the material to form rigid and complex 3D shapes capable of use for a variety of medical and non-medical purposes. These support devices typically also include an adhesive material allowing the device to be attached to a subject's skin and/or mounted on a surface (e.g., wall, etc.). In particular, described herein are methods of manufacturing, assembling, and using adhesive support devices.

A bandage comprising a base substrate, a wound covering portion, a first side coupling member and a second side coupling member, and a first side and second side adhesive portion. The base substrate includes a central region, a first side region and a second side region, and comprises an elastic member. The wound covering portion is positioned over the central region. The first side coupling member extends over the first side region. The second side coupling member extending over the second region. The first side adhesive portion is positioned on the first side region. The second side adhesive portion positioned on the second side region. A method of use as well as a protective carrier are likewise disclosed.

Dressings, systems, and methods for treating a tissue site on a patient involve allowing liquids from the tissue site or a priming fluid to evaporate and exit the dressing through a liquid-impermeable, vapor-permeable membrane. The dressing is able to process more liquids than would otherwise be possible without evaporation and potentially to create reduced pressure. Other dressings, systems, and methods are disclosed.

A sponge including one or more hemostatic agents and one or more binding agents. At least one of the hemostatic agents is a pregelatinized potato starch. The collective percentage by weight of the one or more hemostatic agents is within the range of approximately one eighth to approximately sixteen times as great as the collective percentage by weight of the one or more binding agents.

A method and apparatus are disclosed for dressing a wound. The apparatus comprises an absorbent layer for absorbing wound exudate, a liquid impermeable, gas permeable filter layer over the absorbent layer, a cover layer comprising at least one orifice and a first liquid and gas permeable transmission layer underlying the absorbent layer. The transmission layer is in fluid communication with the filter layer.

A dressing for treating a tissue site with negative pressure, a sealing tape, methods of use and methods of manufacturing the sealing tape are described. The dressing includes a tissue interface configured to be positioned adjacent to the tissue site and a sealing member configured to be positioned over the tissue interface and the tissue site to form a sealed environment. The dressing also includes a sealing tape having a carrier layer having a first side and a second side, a silicone adhesive layer bonded to the first side of the carrier layer, and an acrylic adhesive layer bonded to the second side of the carrier layer. A plurality of holes extend through the silicone adhesive layer, the acrylic adhesive layer, and the carrier layer. A first release liner is coupled to silicone adhesive layer, and a second release liner is coupled to the acrylic adhesive layer.

The present invention, when used by a live actor, allows users to safely simulate hemorrhaging in some of the most challenging blood vessels in the most challenging anatomical locations such as the carotid artery, the axillary artery, and the inguinal artery. The present invention further provides the ability for users to safely perform hemorrhage control procedures, such as compression and ligation. The simulated wound of the present invention may be compressed to control hemorrhage. The simulated wound receptacle of the present invention may be packed with hemostatic or simple gauze to control hemorrhage. The simulated blood vessel of the device may be ligated with hemostats or other ligating instruments or material and bandaged with pressure dressings to control hemorrhage.

A vented chest wound seal for a penetrating chest wound includes a flexible sheet including a top surface and a bottom surface, an adhesive hydrogel layer covering a portion of the bottom surface of the flexible sheet, and a plurality of vent channels. The adhesive hydrogel layer includes an inner perimeter and an outer perimeter, and the outer perimeter forms a continuous perimeter of hydrogel along a bottom surface of the flexible sheet. A plurality of vent channels, each including a first opening to a space inside of the inner perimeter, extend radially outward to an outer terminal end vent to the top surface of the flexible sheet. The outer terminal end is spaced apart from the outer perimeter of the adhesive hydrogel layer towards the central portion of the chamber.

A wound covering includes a flexible main body, and a sensor element incorporated into the main body. The sensor element includes a mesh formed from a plurality of fibers, and is configured to undergo a change in appearance in response to a change in a parameter associated with wound exudate. The wound covering further includes a supply of therapeutic agent configured to diffuse therapeutic agent from the wound covering into a wound when the wound covering is placed on a wound.